Impact BioMedical, Inc.
IBO
$4.25+3.41%
End of day · as of Oct 11, 2026, 8:01 AM ET
Mkt cap
$7.59M
EV/Sales
237.0
P/E ratio
N/A
FY2025 Revenue
$32,000
EPS (H1 2026)
$-1.67
Gross Margin (FY2025)
-1225.00%
Profit Margin (FY2025)
-36993.75%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Impact BioMedical, Inc. (IBO) is a biotechnology company listed on US.
Latest reported IBO revenue for 2025-12-31 was $32.0K. Net income was -$11.8M. Revenue was down 36.0% from 2022-12-31 to 2025-12-31. IBO currently screens at market cap $7.6M.
Use this IBO research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full IBO income, balance, and cash tables.
Impact BioMedical, Inc. (IBO) is a biotechnology company in the Healthcare sector.
Latest cached Impact BioMedical, Inc. (IBO) revenue for Dec 31, 2025 was $32.0K. Net income was -$11.8M. Statements: https://lician.com/financials/ibo
Impact BioMedical, Inc. (IBO) market capitalization is $7.6M on the latest cached snapshot.
Impact BioMedical, Inc. (IBO) cached previous close $4.11; day range $4.13 – $4.28; volume 3,602. Session quote: https://lician.com/quote/ibo
Impact BioMedical, Inc. (IBO) latest cached earnings event is "IBO earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached IBO filing is 8-K · Oct 9, 2026. Filings: https://lician.com/sec/ibo